MSB 2.08% 94.0¢ mesoblast limited

Cell Therapy News/Articles, page-17893

  1. 2,870 Posts.
    lightbulb Created with Sketch. 2023
    in vivo and in vitro are not used inappropriately in my view in this post - reg's faith that the IL-2R potency assay wasn't used before though is clearly incorrect as any checking of the MSB submission to ODAC using the wayback machine can make clear - MSB has ALWAYS used both TNFR1 and Il2Ralpha.

    JB1975- I am asking questions JB, seeking input from any experts who follow these threads. I thought a different type of potency assay- still using IL2 - but different in some form or other- had been used but then changed to another .

    I don't mind being wrong- asking questions- seeking clarification etc.

    The query I have - of learned posters - is something from a IL2Ra assay has been presented that led to the FDA and the company changing their course.

    You have previously been dismissive of the assay - you are sticking to the same line- the main parties involved have overcome a stumbling block.

    Some-one, besides me, is missing something


    Silviu Itescu, Philip Krause, Eric Rose, Nicole Verdun, JB1975


    Veni Vidi Vici

    or

    Nero fiddles cum Roma ardet



    Well done to all Olympians- a special breed


    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.